Syndrome de Werner
Revu par Dr Doug McKechnie, MRCGPDernière mise à jour par Dr Philippa Vincent, MRCGPDernière mise à jour 21 sept. 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Version audio
- Ajouter aux sources préférées sur Google
Professionnels de la santé
Les articles de référence professionnelle sont conçus pour être utilisés par les professionnels de la santé. Ils sont rédigés par des médecins britanniques et basés sur des preuves de recherche, des directives britanniques et européennes. Vous pouvez trouver l'un de nos articles de santé plus utile.
Synonyms: adult premature ageing syndrome, adult progeria
What is Werner's syndrome?
Werner's syndrome (WS) is an extremely rare, autosomal recessive, systemic disease which is associated with features of premature aging and cancer predisposition. The syndrome is named after C. W. Otto Werner, a German physician (1879-1936).
Pathogenèse
Interest in Werner's syndrome (WS) is fuelled in part by the observation that transcription aberrations in WS are similar to those found in normal ageing.1 In WS, the gene defect is known to affect WRN (found on chromosome 8) encoding Werner protein, a nuclear protein with helicase and exonuclease activity important in maintaining and repairing DNA, particularly where double-strand breaks occur.2 3 WRN gene mutations encode an abnormally shortened Werner protein.
More than 50 different disease-causing mutations in the WRN gene have been identified in WS patients.
How common is Werner's syndrome? (Epidemiology)
It is extremely rare, with only approximately 1,300 cases reported worldwide since 1916, with 1,000 of those coming from Japan.4
A prevalence of 1/200,000 US population is contrasted with 1/20-40,000 Japanese population (ie 10-20 x more common).
In Japan the frequency of heterozygote carriers of the condition within the general population is estimated as 1/180.3
Symptoms of Werner's syndrome (presentation)
Typically, individuals grow normally until puberty.5
The first symptom is the lack of a teen growth spurt.
Early findings (observed in the 20s) are loss and greying of hair, hoarseness and sclérodermie-like skin changes.
This is followed (typically in the 30s) by bilateral cataracts, type 2 diabetes mellitus, hypogonadism, refractory skin ulcers and osteoporosis.
Most will present to dermatologists or ophthalmologists in the first instance.
Typical signs and symptoms
Suggested diagnostic criteria:6
Bilateral cataracts.
Characteristic skin: tight, atrophic, pigmentary changes, ulceration, hyperkeratosis.
'Bird-like' facies.
Premature greying and/or balding.
Autres signes et symptômes
Type 2 diabetes mellitus.
Hypogonadism and decreased fertility.
Osteosclerosis of distal phalanges of fingers and/or toes.
Soft-tissue calcification.
Premature arteriosclerosis.
Neoplasms: mesenchymal (sarcomas), unusual or multiple types or sites.
High-pitched, squeaky or hoarse voice.
Flat feet.
Diagnostic différentiel7
Atypical Werner's syndrome (WS) - small subset with normal WRN protein. Earlier age of onset and faster progression compared with classic WS.
Hutchinson-Gilford progeria syndrome most closely resembles WS. Neonates with WS appear normal but fail to thrive during their first year, with connective tissue abnormalities becoming apparent in the second and third year, and death usual between 6-20 years.
Early-onset type 2 diabetes mellitus with secondary vascular and skin complications.
Myotonic dystrophy - in view of the young adult-onset cataracts - but other features are different and onset is usually in adulthood.
Scleroderma, mixed connective-tissue disorders, lipodystrophy et Syndrome de Charcot-Marie-Tooth have some skin features similar to WS.
Diagnosing Werner's syndrome (investigations)7
Urinary and serum hyaluronic acid is increased in most individuals.
Sequence analysis of the WRN coding region detects mutations in both alleles for approximately 90%.
Western blot - usually absent Werner protein.
Maladies associées
Werner's syndrome (WS) is associated with several diseases of old age including:
Cancers - x 10 risk of epithelial cancers and mesenchymal sarcomas compared with the general population.4
Cerebral infarction.
Osteoporosis.
Management of Werner's syndrome
Early recognition of the syndrome is helpful, as screening for malignancies and associated diseases such as diabetes may then be performed on a regular basis.
There is no specific treatment available for Werner's syndrome (WS), although surgical intervention and hyperbaric oxygen therapy may be of use in the treatment of refractory skin ulcers.5
Médical
Treatment of diabetes - glitazones are thought to be particularly effective.8
Cholesterol lowering where lipid profile is abnormal.9
Standard treatments for malignancies and ischaemic heart disease.
Preliminary mouse studies suggest vitamin C supplementation may be beneficial.10
New studies have demonstrated involvement of particular genes and considered activation of P13K/AKT activation to improve the possible future benefits of stem cell based therapy. 11
Chirurgical
Specific surgical procedures may be required to treat complications such as cataracts and contractures.
Conseil génétique
Fertility is much reduced but there are recorded instances of individuals of both sexes having children.
Obligate carrier status of all affected individual's children.
For siblings of an affected individual, there is a 1 in 4 risk of having the disease and a 1 in 2 risk of carrier status as a sibling.
Relatives of affected individuals should have increased cancer surveillance.3
Pronostic
The life span of individuals with Werner's syndrome (WS) is reduced. Death previously occurred on average in the mid-40s, commonly as a result of malignancy or myocardial infarction.4
However, recent studies suggest an increase in the average age of death to the late 50s with fewer dying from vascular events. 12
Prevention of Werner's syndrome
Prenatal screening may be available to parents who are considered at high risk of having an affected child.
Mises à jour exclusives pour les professionnels de la santé
Restez informé des dernières mises à jour cliniques, des perspectives professionnelles et des conseils fondés sur des preuves. La newsletter Patient Pro sélectionne des contenus essentiels pour les professionnels de santé—livrés directement dans votre boîte de réception.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.
Lectures complémentaires et références
- Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020; Orphanet Journal of Rare Disease
- Kyng KJ, Bohr VA; Kyng KJ, Bohr ; Gene expression and DNA repair in progeroid syndromes and human aging. Ageing Res Rev. 2005 Nov;4(4):579-602. Epub 2005 Oct 24.
- Lan L, Nakajima S, Komatsu K, et al; Accumulation of Werner protein at DNA double-strand breaks in human cells. J Cell Sci. 2005 Sep 15;118(Pt 18):4153-62. Epub 2005 Sep 1.
- Muftuoglu M, Oshima J, von Kobbe C, et al; The clinical characteristics of Werner syndrome: molecular and biochemical diagnosis. Hum Genet. 2008 Sep 23.
- Yamamoto K, Imakiire A, Miyagawa N, et al; A report of two cases of Werner's syndrome and review of the literature. J Orthop Surg (Hong Kong). 2003 Dec;11(2):224-33.
- Werner syndrome, Online Mendelian Inheritance in Man (OMIM)
- Nakura J, Wijsman EM, Miki T, et al; Homozygosity mapping of the Werner syndrome locus (WRN). Genomics. 1994 Oct;23(3):600-8.
- Gene review; Werner syndrome. Last updated 2007; funded by NIH
- Hattori S, Kasai M, Namatame T, et al; Pioglitazone treatment of insulin resistance in a patient with Werner's syndrome. Diabetes Care. 2004 Dec;27(12):3021-2.
- Leistritz DF, Hanson N, Martin GM, et al; Werner Syndrome
- Janniger CK et al; Werner Syndrome, Medscape, Jan 2010
- Tu J, Wan C, Zhang F, et al; Genetic correction of Werner syndrome gene reveals impaired pro-angiogenic function and HGF insufficiency in mesenchymal stem cells. Aging Cell. 2020 May;19(5):e13116. doi: 10.1111/acel.13116. Epub 2020 Apr 22.
- Lifetime extension and the recent cause of death in Werner syndrome: a retrospective study from 2011 to 2020; Orphanet Journal of Rare Disease
À propos de l'auteurVoir la biographie complète

Dr Philippa Vincent, MRCGP
Médecin généraliste, Auteur médical
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dr Philippa Vincent est un médecin généraliste du NHS travaillant dans le nord de Londres.
À propos du critiqueVoir la biographie complète

Dr Doug McKechnie, MRCGP
Rédacteur Médical
MA, MBBS, MSc, DRCOG, MRCP(UK), MRCGP(2021), FHEA
Le Dr Doug McKechnie est un médecin généraliste du NHS travaillant à Londres. Il travaille à plein temps en clinique et est également le chef adjoint du module de Pratique Clinique et Professionnelle à l'École de Médecine de l'University College London.
Historique de l'article
Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.
Article également disponible en Anglais, Allemand, Espagnol, Français, Italien, Portugais, Hindi, Hébreu, Arabe, and Suédois.
Prochaine révision prévue : 19 sept. 2028
21 sept. 2023 | Dernière version

Demandez, partagez, connectez-vous.
Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

Vous ne vous sentez pas bien ?
Évaluez vos symptômes en ligne gratuitement
Plus en dermatologie
- Angio-œdème
- Balanite
- Éruptions cutanées courantes chez les enfants
- Pied diabétique
- Ecthyma
- Érythème marginé rhumatismal
- Érythème toxique du nouveau-né
- Pemphigus bénin familial
- Herpès génital simplex
- Maladie main-pied-bouche
- Mastocytose et troubles des mastocytes
- Rougeole
- Melasma
- Maladie mixte du tissu conjonctif
- Excoriation névrotique et acné excoriée
- Hyperpigmentation post-inflammatoire de la peau
- Syndrome de la peau ébouillantée staphylococcique
- Corticostéroïdes topiques pour la peau
- Toxocarose
- Eczéma variqueux